Affordify, Inc. v. Medac, Inc.

District Court, D. Colorado·Decided August 18, 2021·No. 1:19-cv-02082·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLORADO Civil Action No. 19-cv-02082-RMR-NRN AFFORDIFY, INC., Plaintiff, V. MEDAC, INC., MIRAMED GLOBAL SERVICES, INC., and ANESTHESIA BUSINESS CONSULTANTS, LLC, Defendants. ORDER RE: DEFENDANTS’ MOTION FOR LEAVE TO DISCLOSE RETAINED REBUTTAL EXPERT OR IN THE ALTERNATIVE TO STRIKE PLAINTIFF’S EXPERT (DKT. #139)

N. REID NEUREITER United States Magistrate Judge This matter is before me on Defendants’ Motion for Leave to Disclose Retained Rebuttal Expert or in the Alternative to Strike Plaintiff's Expert (the “Motion”). (Dkt. #139.) Defendants’ Motion was referred to me by Judge Christine M. Arguello on May 13, 2021. (Dkt. #140.)' Plaintiff filed a response in opposition, (Dkt. #147) and Defendants filed a reply. (Dkt. #150.) | heard oral argument on the Motion on July 21, 2021. (See Dkt. # 152 (courtroom minutes).) Pursuant to my order, Defendants submitted their proposed expert rebuttal report on July 21, 2021. (Dkt. #153-1.) Plaintiff responded to the proposed report on July 23, 2021 (Dkt. #154.) | have taken judicial

1 This case was reassigned to Judge Regina M. Rodriguez on July 6, 2021. (See DKt. #151.)

notice of the file and considered the briefing and the supplemental documents, as well as argument of the parties and applicable law. BACKGROUND | have previously detailed the factual background of this case in the Order Denying Defendants’ Motion to Exclude or Limit Plaintiff's Expert James T. Schmid’s Opinions, entered on April 30, 2021. (Dkt. #126.) The Court assumes the parties’ familiarity with the history of this matter and will not repeat it here except as necessary. | entered the Scheduling Order in this matter on September 26, 2019. (Dkt. #21.) Per the Scheduling Order, in relevant part, the parties were to identify their affirmative experts by May 1, 2020 and rebuttal experts by June 1, 2020. (/d.) There is no dispute that Mr. Schmid’s expert report was timely disclosed in May 2020. On June 29, 2020, Defendants disclosed two rebuttal expert witnesses, Tony Mira and Fred Fazio (the Chief Executive Officer and Chief Financial Officer, respectively, of MiraMed), to “address the multiple incorrect assumptions in Mr. Schmid’s report.” (Dkt. #139 at Defendants deposed Mr. Schmid on July 23, 2020. Defendants filed their Motion to Exclude or Limit Plaintiff's Expert James T. Schmiad’s Opinions or in the Alternative for a Daubert Hearing (“Motion to Exclude”) (Dkt. #116) on February 14, 2021, arguing that Mr. Schmid’s opinion should be excluded because he: (1) relied on insufficient facts and data; (2) used an unreliable method; and (3) wrongly applied his method. Plaintiff responded to this motion on March 10, 2021, and included a six-page affidavit from Mr. Schmid. (Dkt. ##123 &123-4.)

2 lf Mr. Mira and Mr. Fazio were not disclosed until June 29, 2020, then it appears this disclosure was untimely under the Scheduling Order. However, no party has raised this issue to the Court and, at this point, any objection is waived.

Ultimately, | denied Defendants’ Motion to Exclude. (Dkt. #126.) Defendants filed an objection to the Order (see Dkt. #132), which remains pending before Judge Rodriguez. On May 11, 2021,° Defendants filed the pending Motion, seeking leave to designate a retained expert witness to rebut Mr. Schmid’s expert report, which Plaintiff disclosed more than a year earlier in May 2020. Alternatively, Defendants argue that, if | deny the Motion, | should exclude Mr. Schmid’s testimony. Plaintiff contends that Defendants have failed to show good cause for modifying the scheduling order and that Defendants are impermissibly asking me to reconsider my prior ruling on the motion to exclude Mr. Schmid’s opinion. LEGAL STANDARD Federal Rule of Civil Procedure 26 provides, in relevant part, that a party “must disclose to the other parties the identity of any witness it may use at trial to present evidence under Federal Rule of Evidence 702, 703, or 705.” Fed. R. Civ. P. 26(a)(2)(A). Such disclosures must be made “at the times and in the sequence that the court orders.” Fed. R. Civ. P. 26(a). In the present matter, | ordered that the parties designate any rebuttal experts by June 1, 2020. (See Dkt. #21.) The parties dispute whether Rule 16 or Rule 37 governs Defendants’ request for leave to make the delayed disclosure. Regardless, the parties addressed both standards in their briefing and had the opportunity to be heard at oral argument. Allowing Defendants to designate a rebuttal expert now, more than a year later, would clearly necessitate modifying the Scheduling Order. Thus, Rule 16 applies to the

3 Defendants filed their first Motion for Leave to Disclose Retained Rebuttal Expert or in the Alternative to Strike Plaintiff's Expert on May 7, 2021, but it was denied without prejudice for failure to comply with D.C.COLO.L.CivR 7.1(a). (See Dkt. ##136 & 137.)

present dispute and provides, in relevant part, “[a] schedule may be modified only for good cause and with the judge’s consent.” Fed. R. Civ. P. 16(b)(4); see also D.C.COLO.LCivR 16.1 (“The schedule established by a scheduling order shall not be modified except upon a showing of good cause and by leave of court.”). Generally, the good cause standard focuses on the moving party’s diligence in attempting to meet the

scheduled deadline: Rule 16(b) does not focus on the bad faith of the movant, or the prejudice to the opposing party. Rather, it focuses on the diligence of the party seeking leave to modify the scheduling order to permit the proposed amendment. Properly construed, ‘good cause’ means that scheduling deadlines cannot be met despite a party's diligent efforts. In other words, this court may ‘modify the schedule on a showing of good cause if [the deadline] cannot be met despite the diligence of the party seeking the extension.’ Carelessness is not compatible with a finding of diligence and offers no reason for a grant of relief. Pumpco, Inc. v. Schenker Int’l, Inc., 204 F.R.D. 667, 668 (D. Colo. 2001) (citing Colo. Visionary Acad. v. Medtronic, Inc., 194 F.R.D. 684, 687 (D. Colo. 2000)). However, “[w]hat constitutes good cause sufficient to justify the modification of a scheduling order necessarily varies with the circumstances of each case.” 6A Charles Alan Wright & Arther R. Miller, Federal Practice & Procedure § 1522.2 (3d ed.) Though Rule 16 governs modifications of the Scheduling Order, Rule 37 should not be entirely ignored. Here, Defendants sought leave to amend the Scheduling Order to permit the untimely disclosure of a rebuttal expert witness. It seems that if Defendants had instead disclosed the report without seeking leave to do so, Rule 37 would apply. See Fountain Valley Inv. Partners, LLC v. Cont’l W. Ins. Co., No. 14-CV- 01906-MSK-NYW, 2015 WL 6376000, at *4 (D. Colo. Oct. 22, 2015) (applying Rule 37 where Plaintiff had designated expert witness out of time, and explaining that “had Plaintiff sought leave to amend the designation deadline rather than simply designate [the expert], [the Court] would have applied the ‘good cause’ analysis of Rule 16(b)(4))”).

Free access — add to your briefcase to read the full text and ask questions with AI

Affordify, Inc. v. Medac, Inc., (D. Colo. 2021).

Affordify, Inc. v. Medac, Inc. (Affordify, Inc. v. Medac, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related